Top

Published in:

01-10-2021 | Original Article

Effect of Psoralen on the Intestinal Barrier and Alveolar Bone Loss in Rats With Chronic Periodontitis

Authors: Hua Liu, Yingjie Xu, Qi Cui, Ning Liu, Fuhang Chu, Beibei Cong, Yingtao Wu

Published in: Inflammation | Issue 5/2021

Abstract

To study the effects of psoralen on the intestinal barrier and alveolar bone loss (ABL) in rats with chronic periodontitis. Fifty-two 8-week-old specific pathogen-free (SPF) male Sprague-Dawley (SD) rats were randomly divided into the following four groups: Control group (Control), psoralen group of healthy rats (Pso), periodontitis model group (Model), and psoralen group of periodontitis rats (Peri+Pso). The alveolar bone resorption of maxillary molars was observed via haematoxylin-eosin staining and micro-computed tomography. The expression level of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in periodontal tissues was evaluated by immunofluorescence staining. The changes in serum tumour necrosis factor (TNF)-α, interleukin (IL)-10, IL-6, intestinal mucosal occludin, and claudin-5 were detected using enzyme-linked immunosorbent assay (ELISA). The level of intestinal mucosal NOD2 was detected using immunohistochemical methods. DNA was extracted from the intestinal contents and the 16s rRNA gene was sequenced using an Illumina MiSeq platform. The expression of NOD2 protein in the intestinal tract of periodontitis rats decreased after intragastric psoralen administration. Psoralen increased the intestinal microbiota diversity of rats. The level of serum pro-inflammatory factor TNF-α decreased and the level of anti-inflammatory factor IL-10 increased. ABL was observed to be significantly decreased in rats treated with psoralen. Psoralen decreased the RANKL/OPG ratio of periodontitis rats. Psoralen may affect the intestinal immune barrier and ecological barrier, mediate immune response, promote the secretion of anti-inflammatory factor IL-10, and reduce the secretion of the pro-inflammatory factor TNF-α, thus reducing ABL in experimental periodontitis in rats.

Slots, J. 2013. Periodontology: Past, present, perspectives. Periodontology 2000 62: 7–19. https://doi.org/10.1111/prd.12011.CrossRefPubMed

Di Paola, R., S. Marzocco, E. Mazzon, F. Dattola, F. Rotondo, D. Britti, M. De Majo, T. Genovese, and S. Cuzzocrea. 2004. Effect of aminoguanidine in ligature-induced periodontitis in rats. Journal of Dental Research 83: 343–348. https://doi.org/10.1177/154405910408300414.CrossRefPubMed

Palombo, E.A. 2011. Traditional medicinal plant extracts and natural products with activity against oral bacteria: Potential application in the prevention and treatment of oral diseases. Evidence-based Complementary and Alternative Medicine 2011. https://doi.org/10.1093/ecam/nep067.

Lamont, R.J., H. Koo, and G. Hajishengallis. 2018. The oral microbiota: Dynamic communities and host interactions. Nature Reviews Microbiology 16: 745–759. https://doi.org/10.1038/s41579-018-0089-x.CrossRefPubMedPubMedCentral

Kamer, A., R.G. Craig, A.P. Dasanayake, M. Brys, L. Glodzik-Sobanska, and M.J. de Leon. 2008. Inflammation and Alzheimer’s disease: Possible role of periodontal diseases. Alzheimers Dement 4: 242–250. https://doi.org/10.1016/j.jalz.2007.08.004.CrossRefPubMed

Gao, L., T. Xu, G. Huang, S. Jiang, Y. Gu, and F. Chen. 2018. Oral microbiomes: More and more importance in oral cavity and whole body. Protein & Cell 9: 488–500. https://doi.org/10.1007/s13238-018-0548-1.CrossRef

Xue, L., X. Zou, X.Q. Yang, F. Peng, D.K. Yu, and J.R. Du. 2020. Chronic periodontitis induces microbiota-gut-brain axis disorders and cognitive impairment in mice. Experimental Neurology 326: 113176. https://doi.org/10.1016/j.expneurol.2020.113176.CrossRefPubMed

Holt, S.C., and J.L. Ebersole. 2005. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: The ‘red complex’, a prototype polybacterial pathogenic consortium in periodontitis. Periodontology 2000 38: 72–122. https://doi.org/10.1111/j.1600-0757.2005.00113.x.CrossRefPubMed

Arimatsu, K., H. Yamada, H. Miyazawa, T. Minagawa, M. Nakajima, M.I. Ryder, K. Gotoh, D. Motooka, S. Nakamura, T. Iida, and K. Yamazaki. 2014. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Scientific Reports 4: 4828. https://doi.org/10.1038/srep04828.CrossRefPubMedPubMedCentral

10.

Nakajima, M., K. Arimatsu, T. Kato, Y. Matsuda, T. Minagawa, N. Takahashi, H. Ohno, and K. Yamazaki. 2015. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS One 10: e0134234. https://doi.org/10.1371/journal.pone.0134234.CrossRefPubMedPubMedCentral

11.

Sato, K., N. Takahashi, T. Kato, Y. Matsuda, M. Yokoji, Yamada Miki, T. Nakajima, N. Kondo, N. Endo, R. Yamamoto, Y. Noiri, H. Ohno, and K. Yamazaki. 2017. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system. Scientific Reports 7: 6955. https://doi.org/10.1038/s41598-017-07196-7.CrossRefPubMedPubMedCentral

12.

Arron, J.R., and Y. Choi. 2000. Osteoimmunology-bone versus immune system. Nature 408: 535–536. https://doi.org/10.1038/35046196.CrossRefPubMed

13.

Britton, R.A., R. Irwin, D. Quach, L. Schaefer, J. Zhang, T. Lee, N. Parameswaran, and L.R. McCabe. 2014. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. Journal of Cellular Physiology 229: 1822–1830. https://doi.org/10.1002/jcp.24636.CrossRefPubMedPubMedCentral

14.

Chen, C.H., T.L. Hwang, L.C. Chen, T.H. Chang, C.S. Wei, and J.J. Chen. 2017. Isoflavones and anti-inflammatory constituents from the fruits of Psoralea corylifolia. Phytochemistry 143: 186–193. https://doi.org/10.1016/j.phytochem.2017.08.004.CrossRefPubMed

15.

Chopra, B., A.K. Dhingra, and K.L. Dhar. 2013. Psoralea corylifolia L. (Buguchi)—Folklore to modem evidence: Review. Fitoterapia 90: 44–56. https://doi.org/10.1016/j.fitote.2013.06.016.CrossRefPubMed

16.

Li, X., C. Yu, Y. Hu, X. Xia, Y. Liao, J. Zhang, H. Chen, W. Lu, W. Zhou, and Z. Song. 2018. New application of psoralen and angelicin on periodontitis with anti-bacterial, anti-inflammatory, and osteogenesis effects. Frontiers in Cellular and Infection Microbiology 8: 178. https://doi.org/10.3389/fcimb.2018.00178.CrossRefPubMedPubMedCentral

17.

Yang, Z., J.H. Huang, S.F. Liu, Y.J. Zhao, Z.Y. Shen, Y.J. Wang, and Q. Bian. 2012. The osteoprotective effect of psoralen in ovariectomy-induced osteoporotic rats via stimulating the osteoblastic differentiation from bone mesenchymal stem cells. Menopause-the Journal of the North American Menopause Society 19: 1156–1164. https://doi.org/10.1097/gme.0b013e3182507e18.CrossRef

18.

Feng, L., L. Wang, and X.H. Jiang. 2010. Pharmacokinetics, tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats. Archives of Pharmacal Research 33: 225–230. https://doi.org/10.1007/s12272-010-0206-5.CrossRefPubMed

19.

Wang, Y.X., X.Z. Chen, X.W. Chen, Z.H. Zhou, W.F. Xu, F. Xu, and S.Y. Zhang. 2019. AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats. Journal of Cellular Physiology 234: 10432–10444. https://doi.org/10.1002/jcp.27711.CrossRefPubMed

20.

Jia, X., L. Jia, L. Mo, S. Yuan, X. Zheng, J. He, V. Chen, Q. Guo, L. Zheng, Q. Yuan, X. Xu, and X. Zhou. 2019. Berberine ameliorates periodontal bone loss by regulating gut microbiota. Journal of Dental Research 98: 107–116. https://doi.org/10.1177/0022034518797275.CrossRefPubMed

21.

Chen, S., Y. Wang, Y. Yang, T. Xiang, J. Liu, H. Zhou, and X. Wu. 2017. Psoralen inhibited apoptosis of osteoporotic osteoblasts by modulating IRE1-ASK1-JNK pathway. BioMed Research International 2017: 3524307–3524309. https://doi.org/10.1155/2017/3524307.CrossRefPubMedPubMedCentral

22.

Tang, D.Z., F. Yang, Z. Yang, J. Huang, Q. Shi, D. Chen, and Y.J. Wang. 2011. Psoralen stimulates osteoblast differentiation through activation of BMP signaling. Biochemical and Biophysical Research Communications 405: 256–261. https://doi.org/10.1016/j.bbrc.2011.01.021.CrossRefPubMedPubMedCentral

23.

Wong, R.W., and A.B. Rabie. 2011. Effect of psoralen on bone formation. Journal of Orthopaedic Research 29: 158–164. https://doi.org/10.1002/jor.21124.CrossRefPubMed

24.

Anderson, J.M., and C.M. Van Itallie. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. The American Journal of Physiology 269: G467–G475. https://doi.org/10.1152/ajpgi.1995.269.4.G467.CrossRefPubMed

25.

Chelakkot, C., J. Ghim, and S.H. Ryu. 2018. Mechanisms regulating intestinal barrier integrity and its pathological implications. Experimental and Molecular Medicine 50: 1–9. https://doi.org/10.1038/s12276-018-0126-x.CrossRefPubMed

26.

Claes, A.K., J.Y. Zhou, and D.J. Philpott. 2015. NOD-like receptors: Guardians of intestinal mucosal barriers. Physiology (Bethesda) 30: 241–250. https://doi.org/10.1152/physiol.00025.2014.CrossRef

27.

Philpott, D.J., M.T. Sorbara, S.J. Robertson, K. Croitoru, and S.E. Girardin. 2014. NOD proteins: Regulators of inflammation in health and disease. Nature Reviews. Immunology 14: 9–23. https://doi.org/10.1038/nri3565.CrossRefPubMed

28.

Robertson, B.R., J.L. O’Rourke, B.A. Neilan, P. Vandamme, S.L.W. On, J.G. Fox, and A. Lee. 2005. Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. International Journal of Systematic and Evolutionary Microbiology 55: 1199–1204. https://doi.org/10.1099/ijs.0.63472-0.CrossRefPubMed

29.

Caruso, R., N. Warner, N. Inohara, and G. Nunez. 2014. NOD1 and NOD2: Signaling, host defense, and inflammatory disease. Immunity 41: 898–908. https://doi.org/10.1016/j.immuni.2014.12.010.CrossRefPubMedPubMedCentral

30.

Barnich, N., J.E. Aguirre, H.C. Reinecker, R. Xavier, and D.K. Podolsky. 2005. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kappa B activation in muramyl dipeptide recognition. The Journal of Cell Biology 170: 21–26. https://doi.org/10.1083/jcb.200502153.CrossRefPubMedPubMedCentral

31.

Yatsonsky Ii, D., K. Pan, V.B. Shendge, J. Liu, and N.A. Ebraheim. 2019. Linkage of microbiota and osteoporosis: A mini literature review. World Journal of Orthopedics 10: 123–127. https://doi.org/10.5312/wjo.v10.i3.123.CrossRefPubMedPubMedCentral

32.

Rizzoli, R. 2019. Nutritional influence on bone: Role of gut microbiota. Aging Clinical and Experimental Research 31: 743–751. https://doi.org/10.1007/s40520-019-01131-8.CrossRefPubMed

33.

Ohlsson, C., and K. Sjogren. 2015. Effects of the gut microbiota on bone mass. Trends in Endocrinology and Metabolism 26: 69–74. https://doi.org/10.1016/j.tem.2014.11.004.CrossRefPubMed

34.

Atarashi, K., T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose, G. Cheng, S. Yamasaki, T. Saito, Y. Ohba, T. Taniguchi, K. Takeda, S. Hori, I.I. Ivanov, Y. Umesaki, K. Itoh, and K. Honda. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337–341. https://doi.org/10.1126/science.1198469.CrossRefPubMed

35.

Everard, A., and P.D. Cani. 2013. Diabetes, obesity and gut microbiota. Best Practice & Research. Clinical Gastroenterology 27: 73–83. https://doi.org/10.1016/j.bpg.2013.03.007.CrossRef

36.

Wang, J., Y. Wang, W. Gao, B. Wang, H. Zhao, Y. Zeng, Y. Ji, and D. Hao. 2017. Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. PeerJ 5: e3450. https://doi.org/10.7717/peerj.3450.CrossRefPubMedPubMedCentral

37.

Das, M., O. Cronin, D.M. Keohane, E.M. Cormac, H. Nugent, M. Nugent, C. Molloy, P.W. O’Toole, F. Shanahan, M.G. Molloy, and I.B. Jeffery. 2019. Gut microbiota alterations associated with reduced bone mineral density in older adults. Rheumatology (Oxford) 58: 2295–2304. https://doi.org/10.1093/rheumatology/kez302.CrossRef

38.

Li, C., Q. Huang, R. Yang, Y. Dai, Y. Zeng, L. Tao, X. Li, J. Zeng, and Q. Wang. 2019. Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China. Osteoporosis International 30: 1003–1013. https://doi.org/10.1007/s00198-019-04855-5.CrossRefPubMed

39.

Ma, S., J. Qin, Y. Hao, and L. Fu. 2020. Association of gut microbiota composition and function with an aged rat model of senile osteoporosis using 16S rRNA and metagenomic sequencing analysis. Aging (Albany NY) 12: 10795–10808. https://doi.org/10.18632/aging.103293.CrossRef

40.

Pascale, A., N. Marchesi, C. Marelli, A. Coppola, L. Luzi, S. Govoni, A. Giustina, and C. Gazzaruso. 2018. Microbiota and metabolic diseases. Endocrine 61: 357–371. https://doi.org/10.1007/s12020-018-1605-5.CrossRefPubMed

41.

Jones, R.M., L. Luo, C.S. Ardita, A.N. Richardson, Y.M. Kwon, J.W. Mercante, A. Alam, C.L. Gates, H. Wu, P.A. Swanson, J.D. Lambeth, P.W. Denning, and A.S. Neish. 2013. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. The EMBO Journal 32: 3017–3028. https://doi.org/10.1038/emboj.2013.224.CrossRefPubMedPubMedCentral

42.

Grassi, F., G. Tell, M. Robbie-Ryan, Y. Gao, M. Terauchi, X. Yang, M. Romanello, D.P. Jones, M.N. Weitzmann, and R. Pacifici. 2007. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proceedings of the National Academy of Sciences of the United States of America 104: 15087–15092. https://doi.org/10.1073/pnas.0703610104.CrossRefPubMedPubMedCentral

43.

Lappin, D.F., C.P. Macleod, A. Kerr, T. Mitchell, and D.F. Kinane. 2001. Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clinical and Experimental Immunology 123: 294–300. https://doi.org/10.1046/j.1365-2249.2001.01448.x.CrossRefPubMedPubMedCentral

44.

Yamazaki, K., K. Tabeta, T. Nakajima, Y. Ohsawa, K. Ueki, H. Itoh, and H. Yoshie. 2001. Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early onset periodontitis. Journal of Clinical Periodontology 28: 828–832. https://doi.org/10.1034/j.1600-051x.2001.028009828.x.CrossRefPubMed

45.

Moore, K.W., R.D. Malefyt, R.L. Coffman, and A. O’Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683–765. https://doi.org/10.1146/annurev.immunol.19.1.683.CrossRefPubMed

Title: Effect of Psoralen on the Intestinal Barrier and Alveolar Bone Loss in Rats With Chronic Periodontitis
Authors: Hua Liu
Yingjie Xu
Qi Cui
Ning Liu
Fuhang Chu
Beibei Cong
Yingtao Wu
Publication date: 01-10-2021
Publisher: Springer US
Published in: Inflammation / Issue 5/2021
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-021-01462-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone

Ganoderic Acid A Alleviates OVA-Induced Asthma in Mice

Benzoylaconine Modulates LPS-Induced Responses Through Inhibition of Toll-Like Receptor-Mediated NF-κB and MAPK Signaling in RAW264.7 Cells

CircANKRD36 Knockdown Suppressed Cell Viability and Migration of LPS-Stimulated RAW264.7 Cells by Sponging MiR-330

9,10-Anhydrodehydroartemisinin Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Th1 and Th17 Cell Differentiation

Compounds DRG and DAG, Two Phenol Glycosides, Inhibit TNF-α-stimulated Inflammatory Response through Blocking NF-kB/AKT/JNK Signaling Pathways in MH7A Cells

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage